Showing 65,621 - 65,640 results of 104,171 for search '(( e point decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.85s Refine Results
  1. 65621

    Table_1_Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis.pdf by Tatjana Welzel (11753417)

    Published 2021
    “…Colchicine was started at 0.5–1.0 mg/day. DA was captured by physician (PGA) and patient/parent (PPGA) global assessment on a 10 cm visual analog scale, categorized as mild (<2), moderate (2–4), and high (≥5). …”
  2. 65622

    Activation of the IL-2 receptor is associated with induction of JAK/STAT protein expression. by Arnold H. Zea (411800)

    Published 2016
    “…N = 3 in individual groups. (D) Nuclear STAT 5a protein expression in podocytes was significantly decreased at both time points with IL-2 stimulation (*, P<0.0001) compared to unstimulated podocytes. …”
  3. 65623

    MCF7-luc-GFP-mCherry breast tumor response to administration of BPR0L075 observed by bioluminescence. by Li Liu (75607)

    Published 2012
    “…Control mice show highly reproducible signal, though with significant increase after 24 hours, whereas treated mice show severely decreased signal at the 2 hour time point, though with progressive recovery over 24 hours; (F) The control mice in “E” (dashed lines same symbol designation) were treated with drug on the second day and maximum light emission is plotted. …”
  4. 65624

    The CCDC66 depletion disrupts endocytosis and membrane recycling near cilia. by Jovana Deretic (13113617)

    Published 2025
    “…<b>(B)</b> Measured is the mean pixel intensity of a circular 5 μm<sup>2</sup> area centered at the ciliary base of each cell in <b>(A)</b>. …”
  5. 65625

    Clinical and Imaging Characteristics of Posterior Scleritis in Children by Ayala Katzir (20605679)

    Published 2025
    “…Initial echography showed increased posterior scleral thickness (mean±SD 2.9 ± 0.68 mm) with a significant reduction four ± 2 months later (mean±SD 1.85 ± 0.62 mm). …”
  6. 65626

    AS101 prevents renal hypertrophy in STZ injected rats. by Itay Israel Shemesh (669254)

    Published 2014
    “…*p<0.01 increase vs. control group. #p<0.01 decrease vs. STZ+PBS group (n = 5 for Control; n = 7 for STZ+PBS; n = 9 for STZ+AS101 LD; n = 8 for STZ+AS101 HD).…”
  7. 65627

    Effects of CANA on metabolites evaluated by metabolomics. by Dan Nakano (8775380)

    Published 2020
    “…Red circle indicates differential metabolites, which determined the condition of >1.5-fold increase with P<0.05 or <0.7-fold decrease with P<0.05. …”
  8. 65628

    Inhibition of glucose-dependent increased CAPER protein expression suppresses cell proliferation and induces autophagy-mediated vacuolization. by Yun Kyoung Kang (715990)

    Published 2015
    “…Numbers of dots were counted 2 days after transfection with the indicated siRNA. A graph presents numbers of dots counted from the 5 random fields (each point) from three independent experiments. …”
  9. 65629

    Effectiveness of all intervention scenarios. by Yae Jee Baek (9565342)

    Published 2020
    “…We assume the sensitivity of front door screening of 0.5 or 0.7 and the protection rates possibly becoming 0.3, 0.6, or 0.9 as reinforcing protection device. …”
  10. 65630

    Effectiveness of all intervention scenarios. by Yae Jee Baek (9565342)

    Published 2021
    “…We assume the sensitivity of front door screening of 0.5 or 0.7 and the protection rates possibly becoming 0.3, 0.6, or 0.9 as reinforcing protection device. …”
  11. 65631

    Effect of siRNA specific for PIASy and E12 in α-SMA regulation in MCs. by Kazuo Torikoshi (150022)

    Published 2012
    “…<p>(A) PIASy mRNA and protein were reduced by transfection of siRNA against PIASy in mouse MCs. …”
  12. 65632

    Data_Sheet_1_Molecular epidemiological characteristics of Mycobacterium leprae in highly endemic areas of China during the COVID-19 epidemic.docx by Jiaojiao Zhou (432827)

    Published 2024
    “…</p>Results<p>There was an 18.97% decrease in the number of counties and districts reporting cases. …”
  13. 65633

    <sup>1</sup>H NMR in Solution and Solid State Structural Study of Lanthanide(III) Cryptates by C. Platas (2978436)

    Published 1999
    “…We present here a detailed structural comparison, both in the solid state and in aqueous solution, of a complete series of lanthanide cryptate complexes of a Schiff base axial macrobicyclic ligand L of general formula [LnL][NO<sub>3</sub>]<sub>3</sub>·<i>x</i>H<sub>2</sub>O (Ln = La−Lu, Y); the macrobicyclic receptor L is an azacryptand N[(CH<sub>2</sub>)<sub>2</sub>NCH−R−CHN(CH<sub>2</sub>)<sub>2</sub>]<sub>3</sub>N (R = <i>m</i>-C<sub>6</sub>H<sub>2</sub>OH-2-Me-5). …”
  14. 65634

    DataSheet_1_Nationwide Trends of Pediatric Obesity and BMI z-Score From 2017-2021 in China: Comparable Findings From Real-World Mobile- and Hospital-Based Data.docx by Yan Yang (33204)

    Published 2022
    “…The trend of obesity prevalence remained stable with slight decrease, but COVID-19 lockdown caused a significant increase of 1.86% in 2020. …”
  15. 65635

    Mutations at p53 binding sites augment PIK3CA promoter activity. by Snehal M. Gaikwad (279479)

    Published 2013
    “…Representative bioluminescent images of the mice bearing tumors of A2780-MPFT3 cells. Mouse from control and treated group exhibited specific [Fig. 5e3 (pre-treatment)] signals which did not decrease even after two treatments of cisplatin [Fig. 5e3 (post-treatment)].…”
  16. 65636

    Table1_Effect of botanical drugs in improving symptoms of hypertensive nephropathy: Analysis of real-world data, retrospective cohort, network, and experimental assessment.XLSX by Jia-Ming Huan (15185389)

    Published 2023
    “…</p><p>Results: A total of 14 botanical drugs and five symptom communities were obtained from real-world clinical data. …”
  17. 65637

    Image_1_Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infa... by Yang Xiao (146335)

    Published 2021
    “…., opiates, benzodiazepines, P2Y<sub>12</sub> antagonist, propofol) need to be identified in preclinical models.</p><p>Methods: Here, we examined the efficacy of promising cardioprotective compounds [fingolimod (Fingo), empagliflozin (Empa), melatonin (Mela) and nicotinamide riboside (NR)] administered i.v. as bolus before start ischemia. …”
  18. 65638

    Effects of siRNA on RET/PTC3 Junction Oncogene in Papillary Thyroid Carcinoma: From Molecular and Cellular Studies to Preclinical Investigations by Hafiz Muhammad Ali (554920)

    Published 2014
    “…Our aim is to demonstrate <i>in vitro</i> and <i>in vivo</i> molecular and cellular effects of siRNA on <i>RET/PTC3</i> knockdown for therapeutic application.First, we established a novel cell line stably expressing <i>RET/PTC3</i> junction oncogene, named RP3 which was found tumorigenic in nude mice compared to NIH/3T3 mouse fibroblasts. …”
  19. 65639

    Data_Sheet_1_Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces... by Yang Xiao (146335)

    Published 2021
    “…., opiates, benzodiazepines, P2Y<sub>12</sub> antagonist, propofol) need to be identified in preclinical models.</p><p>Methods: Here, we examined the efficacy of promising cardioprotective compounds [fingolimod (Fingo), empagliflozin (Empa), melatonin (Mela) and nicotinamide riboside (NR)] administered i.v. as bolus before start ischemia. …”
  20. 65640